A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.
Blom, DJ; Hala, T; Bolognese, M; Lillestol, MJ; Toth, PD; Burgess, L; Ceska, R; Roth, E; Koren, MJ; Ballantyne, CM; Monsalvo, ML; Tsirtsonis, K; Kim, JB; Scott, R; Wasserman, SM; Stein, EA;
N Engl J Med. 2014; 370(19): 180-119.
Originalarbeiten (Zeitschrift)

Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin.
Schwaiger, JP; Nakada, Y; Berberich, R; Ikewaki, K; Dieplinger, B; Zitt, E; Neyer, U; Salmhofer, H; Kronenberg, F; Koenig, P; Dieplinger, H;
Clin J Am Soc Nephrol. 2013; 8(8): 1319-1326.
Originalarbeiten (Zeitschrift)

The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?
Sellner, J; Weber, MS; Vollmar, P; Mattle, HP; Hemmer, B; Stüve, O;
CNS Neurosci Ther. 2010; 16(6): 362-373.
Übersichtsarbeiten

Atorvastatin Increases the Number of Endothelial Progenitor Cells After Cardiac Surgery: A Randomized Control Study
Spadaccio, C; Pollari, F; Casacalenda, A; Alfano, G; Genovese, J; Covino, E; Chello, M
J CARDIOVASC PHARM. 2010; 55(1): 30-38.
Originalarbeiten (Zeitschrift)

Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.
Sellner, J; Greeve, I; Findling, O; Grandgirard, D; Leib, SL; Mattle, HP;
Clin Exp Immunol. 2008; 152(2):280-284
Originalarbeiten (Zeitschrift)

Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis.
Sellner, J; Greeve, I; Findling, O; Kamm, CP; Minten, C; Engelhardt, B; Grandgirard, D; Leib, SL; Mattle, HP;
Neurochem Int. 2008; 53(1-2):17-21
Originalarbeiten (Zeitschrift)

Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis.
Sellner, J; Greeve, I; Mattle, HP;
Mult Scler. 2008; 14(7):981-984
Originalarbeiten (Zeitschrift)

Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
Riad, A; Du, J; Stiehl, S; Westermann, D; Mohr, Z; Sobirey, M; Doehner, W; Adams, V; Pauschinger, M; Schultheiss, HP; Tschöpe, C;
Eur J Pharmacol. 2007; 569(3):204-211
Originalarbeiten (Zeitschrift)

Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils.
Li, S; Dudczak, R; Koller, E; Baghestanian, M; Ghannadan, M; Minar, E; Pirich, C; Angelberger, P; Virgolini, I; Li, M; Valent, P;
Eur J Clin Pharmacol. 2003; 59(7):507-516
Originalarbeiten (Zeitschrift)

Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients.
Renders, L; Mayer-Kadner, I; Koch, C; Schärffe, S; Burkhardt, K; Veelken, R; Schmieder, RE; Hauser, IA;
Nephrol Dial Transplant. 2001; 16(1): 141-146.
Originalarbeiten (Zeitschrift)